Efficacy of Respiratory Physiotherapy Treatment in Chronic Obstructive Disease.

NCT ID: NCT07204431

Last Updated: 2026-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-01

Study Completion Date

2025-09-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To test the effectiveness of a respiratory physiotherapy treatment plan in patients who have been diagnosed with chronic obstructive pulmonary disease, comparing with two randomized groups, for the performance of different respiratory musculature training protocols. Objectify the data obtained through ultrasound and spirometry, observing the differences obtained at the beginning and end of the study, verifying the efficacy of the PowerBreathe® and Therosold PEP® tools and the effectiveness of diaphragmatic, abdominal and expiratory exercises.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

the PowerBreathe and PEP Therosold tools group.

Group Type EXPERIMENTAL

the PowerBreathe and PEP Therosold tools group.

Intervention Type DEVICE

Initially, the following data were collected from each subject in addition to basic epidemiological data.

perform diaphragmatic breathing and expiratory exercises group.

Group Type ACTIVE_COMPARATOR

the PowerBreathe and PEP Therosold tools group.

Intervention Type DEVICE

Initially, the following data were collected from each subject in addition to basic epidemiological data.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

the PowerBreathe and PEP Therosold tools group.

Initially, the following data were collected from each subject in addition to basic epidemiological data.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with chronic obstructive disease.
* Patients older than 65 years.
* Patients under age.
* Patients with cognitive ability to perform spirometry.
* Patients with physical ability to perform spirometry.

Exclusion Criteria

* Patients without functional limitations in the respiratory system.
* Patients under 65 years of age.
* Patients with no cognitive ability to perform spirometry.
* Patients without physical ability to perform spirometry.
Minimum Eligible Age

65 Years

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Católica de Ávila

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

JORGE VELAZQUEZ SAORNIL

PhD. Physiotherapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad Pontificia de Salamanca

Salamanca, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, Hodgson C, Jones AY, Kho ME, Moses R, Ntoumenopoulos G, Parry SM, Patman S, van der Lee L. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020 Apr;66(2):73-82. doi: 10.1016/j.jphys.2020.03.011. Epub 2020 Mar 30.

Reference Type RESULT
PMID: 32312646 (View on PubMed)

Gosselink R, Bott J, Johnson M, Dean E, Nava S, Norrenberg M, Schonhofer B, Stiller K, van de Leur H, Vincent JL. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med. 2008 Jul;34(7):1188-99. doi: 10.1007/s00134-008-1026-7. Epub 2008 Feb 19.

Reference Type RESULT
PMID: 18283429 (View on PubMed)

Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A, D'Abrosca F, Del Monaco C, Gaudiello G, Paneroni M, Privitera E, Retucci M, Rossi V, Santambrogio M, Sommariva M, Frigerio P. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020 Mar 26;90(1). doi: 10.4081/monaldi.2020.1285.

Reference Type RESULT
PMID: 32236089 (View on PubMed)

Sanchez Mila Z, Rodriguez Sanz D, Martin Nieto A, Jimenez Lobo A, Ramos Hernandez M, Campon Chekroun A, Frutos Llanes R, Barragan Casas JM, Velazquez Saornil J. Effects of a respiratory and neurological rehabilitation treatment plan in post Covid-19 affected university students. Randomized clinical study. Chron Respir Dis. 2024 Jan-Dec;21:14799731241255967. doi: 10.1177/14799731241255967.

Reference Type RESULT
PMID: 38752418 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

092025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.